Related Experiment Videos
Prognostic value of breast cancer aromatase
A Lipton1, R J Santen, S J Santner
1Department of Medicine, Milton S. Hershey Medical Center, Hershey, Pennsylvania 17033.
Cancer
|October 1, 1992
Abstract:
The estrogen receptor, progesterone receptor, and intratumoral aromatase content of 127 breast carcinomas were determined. Patients whose tumor contained either estrogen or progesterone receptors had a longer disease-free interval, but no difference in survival was observed. Measurable aromatase activity was detected in 78 of 113 (69%) tumors. There was no relationship between aromatase activity and disease-free interval or survival.